long-term outcomes with ibrutinib
Published 8 years ago • 3.6K plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
3:39
long-term efficacy and safety with ibrutinib in cll
-
1:22
long-term outcomes and toxicities of ibrutinib in cll
-
1:05
long-term outcomes of patients with cll treated with continuous ibrutinib
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
1:57
updated data on ibrutinib therapy
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
4:40
mcl: long-term safety/efficacy data with ibrutinib
-
2:33
about targeted cancer treatment imbruvica ( ibrutinib )
-
1:35
chemotherapy-free induction with ibrutinib-rituximab
-
1:45
long-term survival of patients with cll treated with ibrutinib compared to age-matched controls
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
4:59
comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk cll
-
3:07
ash 2016 pagel #1 long term follow-up with ibrutinib in cll patients
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
2:00
nivolumab combined with ibrutinib for cll, richter transformation
-
5:29
long term follow-up with ibrutinib venetoclax to treat chronic lymphocytic leukemia